MedTrace Logo

Intracranial Pressure in Experimental Models of Headache

NCT01288781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2012-02-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether increased pressure in the head is elevated in people who suffer from High Altitude Headache. We hypothesise that head pressure will be elevated in people with High Altitude Headache.

Conditions

  • High Altitude Headache

Interventions

DRUG

Acetazolamide

During a forty eight hour hypoxic exposure (3777m), subjects will be given either acetazolamide or placebo at hours fifteen, twenty and thirty two.

DRUG

Lactose monohydrate

During a forty eight hour hypoxic exposure (3777m), subjects will be given either acetazolamide or placebo at hours fifteen, twenty and thirty two.

Sponsors & Collaborators

  • Universita di Verona

    collaborator OTHER

  • North Wales Research Committee, UK

    collaborator UNKNOWN

  • Bangor University

    lead OTHER

Principal Investigators

  • Justin S Lawley, BSc · Bangor University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288781 on ClinicalTrials.gov